53 related articles for article (PubMed ID: 15305154)
1. Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma.
Berg P; Wennberg AM; Tuominen R; Sander B; Rozell BL; Platz A; Hansson J
Melanoma Res; 2004 Aug; 14(4):251-5. PubMed ID: 15305154
[TBL] [Abstract][Full Text] [Related]
2. POLE mutations in families predisposed to cutaneous melanoma.
Aoude LG; Heitzer E; Johansson P; Gartside M; Wadt K; Pritchard AL; Palmer JM; Symmons J; Gerdes AM; Montgomery GW; Martin NG; Tomlinson I; Kearsey S; Hayward NK
Fam Cancer; 2015 Dec; 14(4):621-8. PubMed ID: 26251183
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.
Nikolaou V; Kang X; Stratigos A; Gogas H; Latorre MC; Gabree M; Plaka M; Njauw CN; Kypreou K; Mirmigi I; Stefanaki I; Tsao H
Br J Dermatol; 2011 Dec; 165(6):1219-22. PubMed ID: 21801156
[TBL] [Abstract][Full Text] [Related]
4. A novel CDKN2A variant (p16
Li C; Liu T; Liu B; Hernandez R; Facelli JC; Grossman D
Pigment Cell Melanoma Res; 2019 Sep; 32(5):734-738. PubMed ID: 31001908
[TBL] [Abstract][Full Text] [Related]
5. A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds.
Lang JM; Shennan M; Njauw JC; Luo S; Bishop JN; Harland M; Hayward NK; Tucker MA; Goldstein AM; Landi MT; Puig S; Gruis NA; Bergman W; Bianchi-Scarra G; Ghiorzo P; Hogg D; Tsao H
J Invest Dermatol; 2011 Feb; 131(2):480-6. PubMed ID: 21085193
[TBL] [Abstract][Full Text] [Related]
6. Histologic features of melanoma associated with CDKN2A genotype.
Sargen MR; Kanetsky PA; Newton-Bishop J; Hayward NK; Mann GJ; Gruis NA; Tucker MA; Goldstein AM; Bianchi-Scarra G; Puig S; Elder DE
J Am Acad Dermatol; 2015 Mar; 72(3):496-507.e7. PubMed ID: 25592620
[TBL] [Abstract][Full Text] [Related]
7. Phenocopies in melanoma-prone families with germ-line CDKN2A mutations.
Helgadottir H; Olsson H; Tucker MA; Yang XR; Höiom V; Goldstein AM
Genet Med; 2018 Sep; 20(9):1087-1090. PubMed ID: 29215650
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis.
Taibo A; Paradela S; Suanzes-Hernández J; Balboa-Barreiro V; Amado-Bouza J; Fonseca E
Melanoma Res; 2024 Feb; 34(1):9-15. PubMed ID: 37924530
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy in cutaneous melanoma patients with germline CDKN2A mutations.
Ipenburg NA; van der Hage JA; Newton-Bishop JA; Harland M; Kukutsch NA; Helgadottir H; Vermeer MH; Nieweg OE; van Doorn R
Melanoma Res; 2020 Dec; 30(6):630-631. PubMed ID: 33156206
[No Abstract] [Full Text] [Related]
10. Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.
Taylor NJ; Mitra N; Qian L; Avril MF; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cuellar F; Cust AE; Demenais F; Elder DE; Gerdes AM; Ghiorzo P; Goldstein AM; Grazziotin TC; Gruis NA; Hansson J; Harland M; Hayward NK; Hocevar M; Höiom V; Holland EA; Ingvar C; Landi MT; Landman G; Larre-Borges A; Mann GJ; Nagore E; Olsson H; Palmer JM; Perić B; Pjanova D; Pritchard AL; Puig S; Schmid H; van der Stoep N; Tucker MA; Wadt KAW; Yang XR; Newton-Bishop JA; Kanetsky PA;
J Am Acad Dermatol; 2019 Aug; 81(2):386-394. PubMed ID: 30731170
[TBL] [Abstract][Full Text] [Related]
11. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.
Taylor NJ; Mitra N; Goldstein AM; Tucker MA; Avril MF; Azizi E; Bergman W; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cannon-Albright LA; Cuellar F; Cust AE; Demenais F; Elder DE; Gerdes AM; Ghiorzo P; Grazziotin TC; Hansson J; Harland M; Hayward NK; Hocevar M; Höiom V; Ingvar C; Landi MT; Landman G; Larre-Borges A; Leachman SA; Mann GJ; Nagore E; Olsson H; Palmer JM; Perić B; Pjanova D; Pritchard A; Puig S; van der Stoep N; Wadt KAW; Whitaker L; Yang XR; Newton Bishop JA; Gruis NA; Kanetsky PA;
J Invest Dermatol; 2017 Dec; 137(12):2606-2612. PubMed ID: 28830827
[TBL] [Abstract][Full Text] [Related]
12. Familial features affecting the melanoma risk in
Helgadottir H; Schultz K; Lapins J; Höiom V
Acta Oncol; 2023 Dec; 62(12):1967-1972. PubMed ID: 37801364
[No Abstract] [Full Text] [Related]
13. CD8-Lymphocytic Phenotype Significance in Primary Multiple and Familial Melanoma with Various CDKN2A Mutational Status.
Boşoteanu LA; Gheorghe E; Aşchie M; Cozaru GC; Deacu M; Bălțătescu GI; Orășanu CI; Boşoteanu M
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138255
[No Abstract] [Full Text] [Related]
14. Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.
Taylor NJ; Handorf EA; Mitra N; Avril MF; Azizi E; Bergman W; Bianchi-Scarrà G; Bishop DT; Bressac-de Paillerets B; Calista D; Cannon-Albright LA; Cuellar F; Cust AE; Demenais F; Elder DE; Friedman E; Gerdes AM; Ghiorzo P; Goldstein AM; Grazziotin TC; Hansson J; Hayward NK; Hocevar M; Höiom V; Holland EA; Ingvar C; Landi MT; Landman G; Larre-Borges A; Leachman SA; Mann GJ; Nagore E; Olsson H; Palmer J; Perić B; Pjanova D; Puig S; Schmid H; van der Stoep N; Tucker MA; Wadt KAW; Whitaker L; Yang XR; Newton Bishop JA; Gruis NA; Kanetsky PA;
J Invest Dermatol; 2016 May; 136(5):1066-1069. PubMed ID: 26827760
[No Abstract] [Full Text] [Related]
15. MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability.
Niendorf KB; Goggins W; Yang G; Tsai KY; Shennan M; Bell DW; Sober AJ; Hogg D; Tsao H
J Med Genet; 2006 Jun; 43(6):501-6. PubMed ID: 16169933
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance.
Onnekink AM; Michiels N; Klatte DCF; Oldenburg L; Mieog JSD; Vahrmeijer AL; van Hooft JE; van Leerdam ME; Bonsing BA
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38156443
[No Abstract] [Full Text] [Related]
17. Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma.
Shen A; Arbesman M; Lodha R; Rayman P; Bungo B; Ni Y; Chan T; Gastman B; Ko J; Diaz-Montero CM; Arbesman J; Funchain P
Clin Cancer Res; 2024 Feb; 30(3):564-574. PubMed ID: 38032355
[TBL] [Abstract][Full Text] [Related]
18. Germline cancer-related mutations detected by routine targeted NGS for tumour analysis: A series of 357 melanoma patients.
Garcia-Casado Z; Millán-Esteban D; Manrique-Silva E; Requena C; Traves V; Nagore E
J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):e1384-e1387. PubMed ID: 37422710
[No Abstract] [Full Text] [Related]
19. UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescents.
Liebmann A; Admard J; Armeanu-Ebinger S; Wild H; Abele M; Gschwind A; Seibel-Kelemen O; Seitz C; Bonzheim I; Riess O; Demidov G; Sturm M; Schadeck M; Pogoda M; Bien E; Krawczyk M; Jüttner E; Mentzel T; Cesen M; Pfaff E; Kunc M; Forchhammer S; Forschner A; Leiter-Stöppke U; Eigentler TK; Schneider DT; Schroeder C; Ossowski S; Brecht IB
EBioMedicine; 2023 Oct; 96():104797. PubMed ID: 37716236
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations predisposing to melanoma.
Toussi A; Mans N; Welborn J; Kiuru M
J Cutan Pathol; 2020 Jul; 47(7):606-616. PubMed ID: 32249949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
